With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

[NEW YORK] Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the ...

Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

The profit-sharing continues, but the commercial tide has shifted, and Pfizer is now chasing a different growth engine. Its $10 billion acquisition of Metsera, clinched after a bidding war, signals a ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

The WifOR Institute’s ‘handprint’ quantifies positive socioeconomic impact of pharma products, positing a sustainability ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

COVID-19 mRNA vaccines may enhance the effects of immunotherapy drugs in cancer patients, potentially improving survival rates.

All of these questions deserve urgent exploration. Unfortunately, the discovery comes at a particularly difficult moment for ...